loadpatents
name:-0.013081789016724
name:-0.0090727806091309
name:-0.0034852027893066
BUCKLEY; Dennis Patent Filings

BUCKLEY; Dennis

Patent Applications and Registrations

Patent applications and USPTO patent grants for BUCKLEY; Dennis.The latest application filed is for "survey instrument".

Company Profile
23.24.38
  • BUCKLEY; Dennis - Paso Robles CA
  • Buckley; Dennis - Jamaica Plain MA
  • Buckley; Dennis - Boston MA
  • BUCKLEY; Dennis - Cambridge MA
  • Buckley; Dennis - New Haven CT
  • Buckley; Dennis - Jamaica Plains MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Survey Instrument
App 20220220841 - PELL; Christopher ;   et al.
2022-07-14
Tunable Endogenous Protein Degradation
App 20220135967 - Buckley; Dennis ;   et al.
2022-05-05
Regulating chimeric antigen receptors
Grant 11,311,609 - Bradner , et al. April 26, 2
2022-04-26
Cyano thienotriazolodiazepines and uses thereof
Grant 11,306,105 - Bradner , et al. April 19, 2
2022-04-19
Tunable endogenous protein degradation
Grant 11,293,023 - Buckley , et al. April 5, 2
2022-04-05
Degradation of bromodomain-containing protein 9 (BRD9) by conjugation of BRD9 inhibitors with E3 ligase ligand and methods of use
Grant 11,285,218 - Buckley , et al. March 29, 2
2022-03-29
Calmodulin Inhibitors, Chk2 Inhibitors And Rsk Inhibitors For The Treatment Of Ribosomal Disorders And Ribosomapathies
App 20220008420 - BRADNER; James ;   et al.
2022-01-13
Targeted Protein Degradation To Attenuate Adoptive T-cell Therapy Associated Adverse Inflammatory Responses
App 20210301286 - Bradner; James ;   et al.
2021-09-30
Methods to induce targeted protein degradation through bifunctional molecules
Grant 11,059,801 - Bradner , et al. July 13, 2
2021-07-13
Cyano Thienotriazolodiazepines And Uses Thereof
App 20210206779 - Bradner; James E. ;   et al.
2021-07-08
Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses
Grant 11,046,954 - Bradner , et al. June 29, 2
2021-06-29
Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies
Grant 10,980,808 - Bradner , et al. April 20, 2
2021-04-20
Degradation Of Protein Kinases By Conjugation Of Protein Kinase Inhibitors With E3 Ligase Ligand And Methods Of Use
App 20210061811 - BRADNER; James ;   et al.
2021-03-04
Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use
Grant 10,925,868 - Gray , et al. February 23, 2
2021-02-23
Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use
Grant 10,899,768 - Bradner , et al. January 26, 2
2021-01-26
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules
App 20210015929 - Bradner; James ;   et al.
2021-01-21
Methods to induce targeted protein degradation through bifunctional molecules
Grant 10,849,980 - Bradner , et al. December 1, 2
2020-12-01
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules
App 20200317635 - Bradner; James ;   et al.
2020-10-08
Uses of diazepane derivatives
Grant 10,793,571 - Bradner , et al. October 6, 2
2020-10-06
Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligase
Grant 10,730,862 - Crews , et al.
2020-08-04
Bifunctional Molecules For Her3 Degradation And Methods Of Use
App 20200216454 - GRAY; Nathanael S. ;   et al.
2020-07-09
Degradation of tripartite motif-containing protein 24 (TRIM24) by conjugation of TRIM24 inhibitors with E3 ligase ligand and methods of use
Grant 10,702,504 - Bradner , et al.
2020-07-07
Cyano Thienotriazolodiazepines And Uses Thereof
App 20200199150 - Bradner; James E. ;   et al.
2020-06-25
Methods to induce targeted protein degradation through bifunctional molecules
Grant 10,669,253 - Bradner , et al.
2020-06-02
Degradation Of Protein Kinases By Conjugation Of Protein Kinase Inhibitors With E3 Ligase Ligand And Methods Of Use
App 20190374528 - GRAY; Nathanael S. ;   et al.
2019-12-12
Tunable Endogenous Protein Degradation With Heterobifunctional Compounds
App 20190374657 - Buckley; Dennis ;   et al.
2019-12-12
Regulating Chimeric Antigen Receptors
App 20190365875 - Bradner; James ;   et al.
2019-12-05
Methods to induce targeted protein degradation through bifunctional molecules
Grant 10,464,925 - Bradner , et al. No
2019-11-05
Calmodulin Inhibitors, Chk2 Inhibitors And Rsk Inhibitors For The Treatment Of Ribosomal Disorders And Ribosomapathies
App 20190314374 - BRADNER; James ;   et al.
2019-10-17
Degradation Of Protein Kinases By Conjugation Of Protein Kinase Inhibitors With E3 Ligase Ligand And Methods Of Use
App 20190263823 - BRADNER; James ;   et al.
2019-08-29
Degradation Of Bromodomain-containing Protein 9 (brd9) By Conjugation Of Brd9 Inhibitors With E3 Ligase Ligand And Methods Of Us
App 20190247509 - BUCKLEY; Dennis ;   et al.
2019-08-15
Degradation Of Tripartite Motif-containing Protein 24 (trim24) By Conjugation Of Trim24 Inhibitors With E3 Ligase Ligand And Met
App 20190209535 - BRADNER; James ;   et al.
2019-07-11
Diazepane derivatives and uses thereof
Grant 10,308,653 - Bradner , et al.
2019-06-04
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules
App 20190151457 - Bradner; James ;   et al.
2019-05-23
Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase
App 20190127359 - CREWS; CRAIG M. ;   et al.
2019-05-02
Targeted protein degradation using a mutant E3 ubiquitin ligase
Grant 10,239,888 - Bradner , et al.
2019-03-26
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules
App 20190071415 - Bradner; James ;   et al.
2019-03-07
Targeted Protein Degradation Using A Mutant E3 Ubiquitin Ligase
App 20180327419 - Bradner; James ;   et al.
2018-11-15
Methods to induce targeted protein degradation through bifunctional molecules
Grant 10,125,114 - Bradner , et al. November 13, 2
2018-11-13
Tunable Endogenous Protein Degradation
App 20180179522 - Buckley; Dennis ;   et al.
2018-06-28
Targeted Protein Degradation To Attenuate Adoptive T-cell Therapy Associated Adverse Inflammatory Responses
App 20180169109 - Bradner; James ;   et al.
2018-06-21
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules
App 20180134684 - Bradner; James ;   et al.
2018-05-17
Dihydropteridinone derivatives and uses thereof
Grant 9,951,074 - Bradner , et al. April 24, 2
2018-04-24
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules
App 20180085465 - Bradner; James ;   et al.
2018-03-29
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules
App 20180009779 - Bradner; James ;   et al.
2018-01-11
Methods to induce targeted protein degradation through bifunctional molecules
Grant 9,821,068 - Bradner , et al. November 21, 2
2017-11-21
Methods to induce targeted protein degradation through bifunctional molecules
Grant 9,770,512 - Bradner , et al. September 26, 2
2017-09-26
Methods to induce targeted protein degradation through bifunctional molecules
Grant 9,750,816 - Bradner , et al. September 5, 2
2017-09-05
Diazepane derivatives and uses thereof
Grant 9,695,172 - Bradner , et al. July 4, 2
2017-07-04
Methods to induce targeted protein degradation through bifunctional molecules
Grant 9,694,084 - Bradner , et al. July 4, 2
2017-07-04
Dihydropteridinone Derivatives And Uses Thereof
App 20170145013 - Bradner; James E. ;   et al.
2017-05-25
Diazepane Derivatives And Uses Thereof
App 20170145023 - Bradner; James E. ;   et al.
2017-05-25
Uses Of Diazepane Derivatives
App 20170008895 - Bradner; James E. ;   et al.
2017-01-12
Diazepane Derivatives And Uses Thereof
App 20160347749 - Bradner; James E. ;   et al.
2016-12-01
Dihydropteridinone Derivatives And Uses Thereof
App 20160347750 - Bradner; James E. ;   et al.
2016-12-01
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules
App 20160243247 - Bradner; James ;   et al.
2016-08-25
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules
App 20160235730 - Bradner; James ;   et al.
2016-08-18
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules
App 20160235731 - Bradner; James ;   et al.
2016-08-18
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules
App 20160176916 - Bradner; James ;   et al.
2016-06-23
Compounds Useful for Promoting Protein Degradation and Methods Using Same
App 20160022642 - Crews; Craig M. ;   et al.
2016-01-28
Compounds Useful For Promoting Protein Degradation And Methods Using Same
App 20150119435 - Crews; Craig ;   et al.
2015-04-30
Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase
App 20140356322 - Crews; Craig M. ;   et al.
2014-12-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed